Corinne Epperly
Direktor/Vorstandsmitglied bei IN8BIO, INC.
Vermögen: 85 246 $ am 30.04.2024
Aktive Positionen von Corinne Epperly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IN8BIO, INC. | Direktor/Vorstandsmitglied | 07.12.2023 | - |
Independent Dir/Board Member | 07.12.2023 | - |
Karriereverlauf von Corinne Epperly
Ehemalige bekannte Positionen von Corinne Epperly
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARGO THERAPEUTICS, INC. | Geschäftsführer | 01.05.2021 | 01.12.2023 |
AVEO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 06.01.2021 | 19.01.2023 |
Independent Dir/Board Member | 06.01.2021 | 19.01.2023 | |
IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2019 | 01.01.2020 |
NOTABLE LABS, LTD. | Geschäftsführer | 01.01.2017 | 01.01.2018 |
Goldman Sachs International
Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Analyst-Equity | 14.04.2010 | 01.10.2010 |
Ausbildung von Corinne Epperly
The University of North Carolina at Charlotte | Doctorate Degree |
University of Virginia | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Israel | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Chief Operating Officer | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
CARGO THERAPEUTICS, INC. | Health Technology |
IN8BIO, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
Goldman Sachs International
Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Finance |
- Börse
- Insiders
- Corinne Epperly
- Erfahrung